Georgia's Online Cancer Information Center

Herman Anderson: surviving means sharing the importance of screenings

For Herman Anderson, it’s all about getting people to get screened for cancer. When he was diagnosed with Stage 2 colorectal cancer in 2006, he had not been screened before. And he was 62. He knows better now.

“I went to see my primary care physician because I was having some discomfort,” he said. “Thank goodness, she required that I get a colonoscopy, and that’s how we found it.”

Since then, Herman has spent much of his time in various survivor networking groups sharing his story, but also with fundraising groups to increase access to screenings for those who may not be able to have them otherwise.

“Just a few months after my treatment ended, I joined a colon cancer survivor network. I initially wanted to just go to the meetings and sit and listen. Find comfort in other survivors’ journeys. But now I know I need to share my story and do all I can to make people aware of how cancer can be prevented, or at least beaten.”

Herman admits he may be driven to promote screenings because he feels lucky. Not only from catching the cancer in time after having not been screened when he should have, but also because he got hit with a second blow. When seeing a heart specialist to get ready for the surgery to treat his colorectal cancer, Herman learned that he had three blocked arteries.

“When you are told you have cancer, obviously, that’s already a blow, so I had to condition myself mentally to deal with it. But when they told me about the blockage, it made my situation seem impossible to deal with.”

Fortunately, three stents cleared Herman’s arteries enough to be ready for surgery. With that, and months of radiation and chemotherapy, Herman was on the road to recovery.

“Then I had to go on a diet,” he jokes. Herman says he’s thankful to be able to do that.

Back to Survivors' Voices


Looking Across Disciplines to Share the Breadth of Innovation in Cancer Care

On July 25, 2023, The American Journal of Managed Care® brought its Institute for Value-Based Medicine (IVBM) series to Atlanta, Georgia, where nnovation was on the agenda.


DNA sequencing can lead to longer, better lives for cancer patients. But why do so few get it?

Guidelines now call for everyone diagnosed with advanced lung and colon cancer to get their tumor genetically sequenced, and increasingly, patients with earlier stage disease, as well.


Georgia CORE releases report from Disparities in Cancer Clinical Trials Summit

On Sept. 30, Georgia's cancer experts shared advice and experiences with oncology providers, patient navigators and research managers - all to provide new ways to diversify participation in clinical trials. In February 2023, Georgia CORE issued a report with a recap and actions steps. Download the report >>


Georgia CORE


Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a statewide nonprofit that leverages partnerships and innovation to attract more clinical trials, increase research, and promote education and early detection to improve cancer care for Georgians in rural, urban, and suburban communities across the state.